Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034504987> ?p ?o ?g. }
- W2034504987 endingPage "380" @default.
- W2034504987 startingPage "371" @default.
- W2034504987 abstract "Background: The aim of this phase I trial was to define the maximum tolerated dose (MTD), the dose-limiting toxicity (DLT) and the recommended dose of erlotinib combined with capecitabine and gemcitabine in the treatment of advanced pancreatic cancer (APC). Methods: Gemcitabine was administered intravenously at 1,000 mg/m2/week (days 1, 8 and 15) and oral capecitabine from day 1 to day 21 at 1,660 mg/m2/day. Oral erlotinib was administered daily continuously at escalating doses (28-day cycle). Dose levels (DLs) 1, 2, 3 and 4 were 50, 75, 100 and 125 mg/day, respectively. Pharmacokinetic analysis of the three drugs was performed in the first cycle. Results: Nineteen patients were enrolled. At the MTD (DL4; 125 mg/day erlotinib), 100% of patients developed DLT consisting of grade 4 febrile neutropenia and nonhematological grade 3 events (vomiting, diarrhea, stomatitis, rash). The most common toxicities, regardless of grade, were neutropenia, anemia, rash and diarrhea. Erlotinib systemic exposure was significantly related to the administered dose. Of note, toxicity was significantly associated with elevated systemic exposure of capecitabine anabolites. Conclusion: When combined concurrently with 1,000 mg/m2/week gemcitabine and 1,660 mg/m2/day capecitabine, erlotinib can be administered safely at a daily dose of 100 mg in APC patients." @default.
- W2034504987 created "2016-06-24" @default.
- W2034504987 creator A5023675047 @default.
- W2034504987 creator A5030078141 @default.
- W2034504987 creator A5036107800 @default.
- W2034504987 creator A5050098537 @default.
- W2034504987 creator A5052299853 @default.
- W2034504987 creator A5062113866 @default.
- W2034504987 creator A5066629935 @default.
- W2034504987 creator A5073527562 @default.
- W2034504987 creator A5076113060 @default.
- W2034504987 creator A5084430346 @default.
- W2034504987 creator A5090050048 @default.
- W2034504987 date "2012-01-01" @default.
- W2034504987 modified "2023-10-16" @default.
- W2034504987 title "Phase I Trial of Gemcitabine Combined with Capecitabine and Erlotinib in Advanced Pancreatic Cancer: A Clinical and Pharmacological Study" @default.
- W2034504987 cites W1844681537 @default.
- W2034504987 cites W1931508686 @default.
- W2034504987 cites W1974922522 @default.
- W2034504987 cites W1975723100 @default.
- W2034504987 cites W1986952772 @default.
- W2034504987 cites W1987052913 @default.
- W2034504987 cites W1998936866 @default.
- W2034504987 cites W2012978969 @default.
- W2034504987 cites W2023342413 @default.
- W2034504987 cites W2023372332 @default.
- W2034504987 cites W2035384960 @default.
- W2034504987 cites W2036177395 @default.
- W2034504987 cites W2040555399 @default.
- W2034504987 cites W2044310581 @default.
- W2034504987 cites W2044828056 @default.
- W2034504987 cites W2049666882 @default.
- W2034504987 cites W2054383376 @default.
- W2034504987 cites W2064377404 @default.
- W2034504987 cites W2083452953 @default.
- W2034504987 cites W2087675944 @default.
- W2034504987 cites W2091444805 @default.
- W2034504987 cites W2096442753 @default.
- W2034504987 cites W2107376300 @default.
- W2034504987 cites W2107584699 @default.
- W2034504987 cites W2109636091 @default.
- W2034504987 cites W2117105709 @default.
- W2034504987 cites W2119597015 @default.
- W2034504987 cites W2123421436 @default.
- W2034504987 cites W2128259734 @default.
- W2034504987 cites W2130543346 @default.
- W2034504987 cites W2143333875 @default.
- W2034504987 cites W2151253787 @default.
- W2034504987 cites W2156576546 @default.
- W2034504987 cites W2158134441 @default.
- W2034504987 cites W2158734599 @default.
- W2034504987 cites W2160506158 @default.
- W2034504987 cites W2163958696 @default.
- W2034504987 cites W2169836710 @default.
- W2034504987 cites W2318419572 @default.
- W2034504987 doi "https://doi.org/10.1159/000343969" @default.
- W2034504987 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23235319" @default.
- W2034504987 hasPublicationYear "2012" @default.
- W2034504987 type Work @default.
- W2034504987 sameAs 2034504987 @default.
- W2034504987 citedByCount "2" @default.
- W2034504987 countsByYear W20345049872016 @default.
- W2034504987 countsByYear W20345049872021 @default.
- W2034504987 crossrefType "journal-article" @default.
- W2034504987 hasAuthorship W2034504987A5023675047 @default.
- W2034504987 hasAuthorship W2034504987A5030078141 @default.
- W2034504987 hasAuthorship W2034504987A5036107800 @default.
- W2034504987 hasAuthorship W2034504987A5050098537 @default.
- W2034504987 hasAuthorship W2034504987A5052299853 @default.
- W2034504987 hasAuthorship W2034504987A5062113866 @default.
- W2034504987 hasAuthorship W2034504987A5066629935 @default.
- W2034504987 hasAuthorship W2034504987A5073527562 @default.
- W2034504987 hasAuthorship W2034504987A5076113060 @default.
- W2034504987 hasAuthorship W2034504987A5084430346 @default.
- W2034504987 hasAuthorship W2034504987A5090050048 @default.
- W2034504987 hasConcept C121608353 @default.
- W2034504987 hasConcept C126322002 @default.
- W2034504987 hasConcept C197934379 @default.
- W2034504987 hasConcept C2776694085 @default.
- W2034504987 hasConcept C2777063308 @default.
- W2034504987 hasConcept C2777909004 @default.
- W2034504987 hasConcept C2778087573 @default.
- W2034504987 hasConcept C2778375690 @default.
- W2034504987 hasConcept C2778496288 @default.
- W2034504987 hasConcept C2778570526 @default.
- W2034504987 hasConcept C2779438470 @default.
- W2034504987 hasConcept C2779802037 @default.
- W2034504987 hasConcept C2780210213 @default.
- W2034504987 hasConcept C2780258809 @default.
- W2034504987 hasConcept C2780580376 @default.
- W2034504987 hasConcept C29730261 @default.
- W2034504987 hasConcept C526805850 @default.
- W2034504987 hasConcept C71924100 @default.
- W2034504987 hasConcept C90924648 @default.
- W2034504987 hasConcept C98274493 @default.
- W2034504987 hasConceptScore W2034504987C121608353 @default.
- W2034504987 hasConceptScore W2034504987C126322002 @default.
- W2034504987 hasConceptScore W2034504987C197934379 @default.